Celemics, Inc. (KOSDAQ:331920)
15,880
-910 (-5.42%)
At close: Jun 4, 2026
Celemics Revenue
Celemics had revenue of 923.41M KRW in the quarter ending March 31, 2026, a decrease of -46.39%. This brings the company's revenue in the last twelve months to 4.97B, down -24.73% year-over-year. In the year 2025, Celemics had annual revenue of 5.77B, down -14.16%.
Revenue (ttm)
4.97B
Revenue Growth
-24.73%
P/S Ratio
28.79
Revenue / Employee
n/a
Employees
n/a
Market Cap
143.04B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 5.77B | -951.36M | -14.16% |
| Dec 31, 2024 | 6.72B | 141.42M | 2.15% |
| Dec 31, 2023 | 6.58B | -2.15B | -24.65% |
| Dec 31, 2022 | 8.73B | 7.17B | 461.56% |
| Dec 31, 2016 | 1.55B | 812.79M | 109.60% |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Synergy Innovation | 112.84B |
| DENTIS CO.,Ltd | 111.96B |
| Corentec | 102.38B |
| M.I.TECH Co.,Ltd | 66.63B |
| Livsmed | 51.72B |
| BIOBIJOU | 24.92B |
| Finemedix | 9.86B |
| Genolution | 9.82B |